Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05047003 · ClinicalTrials.gov registry record
Oculogica Portable EyeBOX Study
A clinical trial, sponsored by Oculogica.
- Completed
- Registry status
- 100
- Enrollment target
NCT05047003: Completed study, sponsored by Oculogica.
NCT05047003 is a clinical trial that has completed, run by Oculogica. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05047003 has completed, sponsored by Oculogica.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial diagnosis of concussion will also be evaluated.
Primary Outcome
Sensitivity and Specificity compared to the initial diagnosis of concussion
Interventions
- DIAGNOSTIC_TEST EyeBOX Model EBX-4 (Portable version)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-19 |
| Est. Completion | 2022-10-01 |
What the finished NCT05047003 record still lists
NCT05047003 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which EyeBOX Model EBX-4 (Portable version) is the first listed.
NCT05047003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05047003 about?
NCT05047003 is a clinical study titled "Oculogica Portable EyeBOX Study". The objective of this study is to assess the accuracy of a portable version of the EyeBOX device, an eye-tracking based diagnostic, in comparison to a clinical reference standard of concussion. The utility of the portable assessment to aid in the monitoring of symptoms over time after an initial dia...
What is the current status of trial NCT05047003?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2020-12-19. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT05047003?
The interventions under investigation include: EyeBOX Model EBX-4 (Portable version) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05047003?
This trial is sponsored by Oculogica, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI